NDC | 10544-249-06 |
Set ID | 119415c4-86da-1626-e054-00144ff8d46c |
Category | HUMAN OTC DRUG LABEL |
Packager | Blenheim Pharmacal, Inc. |
Generic Name | |
Product Class | Antiemetic |
Product Number | |
Application Number | PART336 |
- Active Ingredient
- Purpose
- Uses
-
WARNINGS
Ask a doctor before use if you have
- glaucoma
- a breathing problem such as emphysema or chronic bronchitis
- trouble urinating due to an enlarged prostate gland
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
When using this product
- you may get drowsy
- avoid alcoholic drinks
- alcohol, sedatives & tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating a machinery
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
- Directions
- Other Information
- Inactive Ingredients
- Questions or Comments
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
MECLIZINE HCL
meclizine hcl tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:10544-249(NDC:0536-3985) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE 12.5 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J) MAGNESIUM STEARATE (UNII: 70097M6I30) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) STEARIC ACID (UNII: 4ELV7Z65AP) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Product Characteristics Color white Score 2 pieces Shape CAPSULE Size 13mm Flavor Imprint Code AP;117 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:10544-249-06 6 in 1 BOTTLE; Type 0: Not a Combination Product 06/18/2010 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part336 06/11/2010 Labeler - Blenheim Pharmacal, Inc. (171434587) Registrant - Blenheim Pharmacal, Inc. (171434587) Establishment Name Address ID/FEI Business Operations Blenheim Pharmacal, Inc. 171434587 repack(10544-249)